Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 33, 472-477, March 1, 1973]
© 1973 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lavrin, D. H.
Right arrow Articles by Terry, W. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lavrin, D. H.
Right arrow Articles by Terry, W. D.

Immunoprophylaxis of Methylcholanthrene-induced Tumors in Mice with Bacillus Calmette-Guérin and Methanol-extracted Residue1

David H. Lavrin, Steven A. Rosenberg, Robert J. Connor and William D. Terry2

Litton Bionetics, Kensington, Maryland 20795 [D. H. L.], and Immunology [S. A. R., W. D. T.] and Biometry Branches [R. J. C.], National Cancer Institute, Bethesda, Maryland 20014

The immunoprophylactic effects of i.p. administration of Bacillus Calmette-Guérin (BCG) and methanol-extracted residue of BCG (MER) on the production of tumors by 3-methylcholanthrene (MCA) in C57BL/6 mice were investigated. At the dose level of MCA used (500 µg i.m.), almost all mice developed tumors. Pretreatment of the mice with BCG either 2 weeks before or 2 weeks after carcinogen administration provided a significant temporary protection, demonstrated by a decreased rate of tumor appearance. Administration of MER at a 0.5-mg dose level conferred relatively little protection against tumor production. In those mice receiving 2.5 mg MER, either on the day of carcinogen administration or both at that time and when the first experimental tumor was found, significant temporary protection against MCA carcinogenesis was obtained. This was demonstrated by a lengthened latent period before tumor production, although subsequently the rate of tumor production was similar to that of the controls.

It is concluded that BCG and MER are capable of affecting the induction of MCA-induced tumors.

1 This investigation was supported by Contract NIH-NCI-G-70-2207 from the National Cancer Institute.

2 To whom requests for reprints should be sent.

Received 8/ 7/72. Accepted 11/22/72.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1973 by the American Association for Cancer Research.